Whichever way you want to crunch the numbers, the opportunity is ENORMOUS.
Tech risk is zero and with BP and now JH on boars, execution risk is also pretty close to zero.
And the icing on the cake, expect very little dilution going forward.
I'm hard pressed to see this stock with an issued cap in excess of 37m shares when all is said and done; and at that stage the company will have tens of millions in the bank.
Stryker to back PuriflOH med-tech?, page-10
Add PO3 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.078M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| PO3 (ASX) Chart |
Day chart unavailable
